JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.38 Cr | ₹-0.01 Cr | ₹0.29 Cr | ₹0.49 Cr | ₹0.08 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-0.38 Cr |
Mar2024 | ₹-0.01 Cr |
Mar2023 | ₹0.29 Cr |
Mar2022 | ₹0.49 Cr |
Mar2021 | ₹0.08 Cr |
How is Deferred Tax Assets / Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-0.38 Cr | Negative | |
Mar2024 | ₹-0.01 Cr | Negative | |
Mar2023 | ₹0.29 Cr | -39.59 | |
Mar2022 | ₹0.49 Cr | 484.34 | |
Mar2021 | ₹0.08 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹571.7 Cr | -2.2% | 0.4% | 49.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -2.2% |
0.4% |
49.5% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses